ROBINUL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Robinul, and when can generic versions of Robinul launch?
Robinul is a drug marketed by Hikma, Robins Ah, and Casper Pharma Llc. and is included in three NDAs.
The generic ingredient in ROBINUL is glycopyrrolate. There are seventeen drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the glycopyrrolate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Robinul
A generic version of ROBINUL was approved as glycopyrrolate by AM REGENT on July 23rd, 1986.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ROBINUL?
- What are the global sales for ROBINUL?
- What is Average Wholesale Price for ROBINUL?
Summary for ROBINUL
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 113 |
| Clinical Trials: | 6 |
| Patent Applications: | 3,886 |
| Drug Prices: | Drug price information for ROBINUL |
| What excipients (inactive ingredients) are in ROBINUL? | ROBINUL excipients list |
| DailyMed Link: | ROBINUL at DailyMed |
Recent Clinical Trials for ROBINUL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| McGill University Health Centre/Research Institute of the McGill University Health Centre | N/A |
| McGill University Health Center | N/A |
| University of Oulu | Phase 4 |
Pharmacology for ROBINUL
| Drug Class | Anticholinergic |
| Mechanism of Action | Cholinergic Antagonists |
US Patents and Regulatory Information for ROBINUL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | ROBINUL | glycopyrrolate | INJECTABLE;INJECTION | 017558-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Casper Pharma Llc | ROBINUL FORTE | glycopyrrolate | TABLET;ORAL | 012827-002 | Approved Prior to Jan 1, 1982 | AA | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Robins Ah | ROBINUL | glycopyrrolate | INJECTABLE;INJECTION | 014764-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Casper Pharma Llc | ROBINUL | glycopyrrolate | TABLET;ORAL | 012827-001 | Approved Prior to Jan 1, 1982 | AA | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ROBINUL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Casper Pharma Llc | ROBINUL | glycopyrrolate | TABLET;ORAL | 012827-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
